Immunovia AB (FRA:1YR) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1YR Immunovia AB FRA:1YR
43 GF Score
Price €0.01
! 4 Warning Signs
View Full Analysis

What is Immunovia AB FFO per Share?

FFO per Share only applies to REITs.

FRA:1YR
43GF Score
Immunovia AB FRA:1YR
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunovia AB Business Description

Other Exchanges IMMNOV:Sweden0G8X:UK
Address Scheelevagen 8, Medicon Village, Lund, SWE, 223 63
Immunovia AB is a diagnostic company. The company develops and commercializes diagnostic tools to detect proteins and autoimmune diseases. The company is developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer. Its technology platform IMMray (TM), is based on antibody microarray analysis.
43GF Score

Get the complete analysis for FRA:1YR

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price